| Issue Date |
Title |
Author(s) |
| 2017 |
Activation of intestinal hypoxia-inducible factor 2 alpha during obesity contributes to hepatic steatosis |
Xie, Cen;Yagai, Tomoki;Luo, Yuhong;Liang, Xianyi;Chen, Tao;Wang, Qiong;Sun, Dongxue;Zhao, Jie;Ramakrishnan, Sadeesh K.;Sun, Lulu;Jiang, Chunmei;Xue, Xiang;Tian, Yuan;Krausz, Kristopher W.;Patterson, Andrew D.;Shah, Yatrik M.;Wu, Yue;Jiang, Changtao;Gonzalez, Frank J. |
| 2017 |
Farnesoid X Receptor Protects Against Low-Dose Carbon Tetrachloride-Induced Liver Injury Through the Taurocholate-JNK Pathway |
Takahashi, Shogo;Tanaka, Naoki;Golla, Srujana;Fukami, Tatsuki;Krausz, Kristopher W.;Polunas, Marianne A.;Weig, Blair C.;Masuo, Yusuke;Xie, Cen;Jiang, Changtao;Gonzalez, Frank J. |
| 2016 |
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism |
Zhang, Limin;Xie, Cen;Nichols, Robert G.;Chan, Siu H. J.;Jiang, Changtao;Hao, Ruixin;Smith, Philip B.;Cai, Jingwei;Simons, Margaret N.;Hatzakis, Emmanuel;Maranas, Costas D.;Gonzalez, Frank J.;Patterson, Andrew D. |
| 27-Oct-2022 |
Hepatic thyroid hormone signalling modulates glucose homeostasis through the regulation of GLP-1 production via bile acid-mediated FXR antagonism |
Yan, Ying;Niu, Zhoumin;Sun, Chao;Li, Peng;Shen, Siyi;Liu, Shengnan;Wu, Yuting;Yun, Chuyu;Jiao, Tingying;Jia, Sheng;Li, Yuying;Fang, Zhong-Ze;Zhao, Lin;Wang, Jiqiu;Xie, Cen;Jiang, Changtao;Li, Yan;Feng, Xiaoyun;Hu, Cheng;Jiang, Jingjing;Ying, Hao |
| 7-Jul-2020 |
An Integrated LC-MS/MS Strategy for Quantifying the Oxidative-Redox Metabolome in Multiple Biological Samples |
Liu, Huiying;Xu, Feng;Gao, Yuqing;Pang, Yuanyuan;Xie, Cen;Jiang, Changtao |
| 2017 |
Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease |
Gonzalez, Frank J.;Jiang, Changtao;Xie, Cen;Patterson, Andrew D. |
| 2017 |
Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease |
Gonzalez, Frank J.;Jiang, Changtao;Xie, Cen;Patterson, Andrew D. |
| 2015 |
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease |
Jiang, Changtao;Xie, Cen;Li, Fei;Zhang, Limin;Nichols, Robert G.;Krausz, Kristopher W.;Cai, Jingwei;Qi, Yunpeng;Fang, Zhong-Ze;Takahashi, Shogo;Tanaka, Naold;Desai, Dhimant;Amin, Shantu G.;Albert, Istvan;Patterson, Andrew D.;Gonzalez, Frank J. |
| 2017 |
An Intestinal Farnesoid X Receptor-Ceramide Signaling Axis Modulates Hepatic Gluconeogenesis in Mice |
Xie, Cen;Jiang, Changtao;Shi, Jingmin;Gan, Xiaoxia;Sun, Dongxue;Sun, Lulu;Wang, Ting;Takahashi, Shogo;Anitha, Mallappa;Krausz, Kristopher W.;Patterson, Andrew D.;Gonzalez, Frank J. |
| Jul-2021 |
Intestinal MYC modulates obesity-related metabolic dysfunction |
Luo, Yuhong;Yang, Shoumei;Wu, Xuan;Takahashi, Shogo;Sun, Lulu;Cai, Jie;Krausz, Kristopher W.;Guo, Xiaozhen;Dias, Henrique B.;Gavrilova, Oksana;Xie, Cen;Jiang, Changtao;Liu, Weiwei;Gonzalez, Frank J. |
| 2015 |
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction |
Jiang, Changtao;Xie, Cen;Lv, Ying;Li, Jing;Krausz, Kristopher W.;Shi, Jingmin;Brocker, Chad N.;Desai, Dhimant;Amin, Shantu G.;Bisson, William H.;Liu, Yulan;Gavrilova, Oksana;Patterson, Andrew D.;Gonzalez, Frank J. |
| Aug-2021 |
Metabolic map of the antiviral drug podophyllotoxin provides insights into hepatotoxicity |
Sun, Dongxue;Gao, Xiaoxia;Wang, Qiao;Krausz, Kristopher W.;Fang, Zhongze;Zhang, Youbo;Xie, Cen;Gonzalez, Frank J. |
| 2017 |
THE ROLE OF TOXIC LIPIDS METABOLIC DISEASE |
Gonzalez, Frank J.;Xie, Cen;Jiang, Changtao;Brocker, Chad;Patterson, Andrew D. |
| 20-Feb-2020 |
Rutaecarpine inhibits KEAP1-NRF2 interaction to activate NRF2 and ameliorate dextran sulfate sodium-induced colitis |
Zhang, Youbo;Yan, Tingting;Sun, Dongxue;Xie, Cen;Wang, Tianxia;Liu, Xiaoyan;Wang, Jing;Wang, Qiong;Luo, Yuhong;Wang, Ping;Yagai, Tomoki;Krausz, Kristopher W.;Yang, Xiuwei;Gonzalez, Frank J. |
